Torino, Italy, January 22 – Resalis Therapeutics, a biotechnology company pioneering microRNA-targeted therapies, today announced the appointment of Sandor Batkai, MD, PhD, as Medical Director. Dr.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback